- Product NDC
- 17089-067
- 11-digit product format
- 170890067
- Labeler code
- 17089
- Product ID
- 17089-067_09280a09-14fa-dd5a-e063-6394a90a3eb0
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- acetylcysteine - ballota foetida - epinephrine - glutathione - interferon gamma-1b - lenograstim - lithium carbonate - melatonin - penicillium glabrum - potassium carbonate - pummelo - rhodotorula rubra - silver nitrate - strychnos nux-vomica seed - sus scrofa cerebral cortex - sus scrofa stomach - sus scrofa superior gastric plexus - sus scrofa thalamus -
- Dosage form
- PELLET
- Route
- ORAL
- Labeler
- Guna spa
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2006-05-23
- Substance
- ACETYLCYSTEINE; BALLOTA FOETIDA; EPINEPHRINE; GLUTATHIONE; INTERFERON GAMMA-1B; LENOGRASTIM; LITHIUM CARBONATE; MELATONIN; PENICILLIUM GLABRUM; POTASSIUM CARBONATE; PUMMELO; RHODOTORULA RUBRA; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRAL CORTEX; SUS SCROFA STOMACH; SUS SCROFA SUPERIOR GASTRIC PLEXUS; SUS SCROFA THALAMUS
- Active strength
- 4; 3; 9; 4; 5; 4; 8; 15; 8; 9; 3; 8; 9; 5; 4; 7; 7; 7 [hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Respiratory Secretion Viscosity [PE], Fungal Proteins [CS], Increased Glutathione Concentration [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Interferon gamma [EPC], Interferon-gamma [CS], Mood Stabilizer [EPC], Mucolytic [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Reduction Activity [MoA], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes